DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally? [Yahoo! Finance]
DaVita Inc. (DVA)
Last davita inc. earnings: 2/10 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.davita.com/investor-relations
Company Research
Source: Yahoo! Finance
DaVita, Inc .DVA has witnessed strong momentum year to date, with its shares up 47.3% compared with the industry 's growth of 14.8%. The S&P 500 composite has risen 19.5% in the same period. DaVita, carrying a Zacks Rank #2 (Buy) at present, is witnessing an upward trend in its stock price, prompted by the company's business model. The optimism, led by a solid second-quarter 2024 performance and the acquisition of dialysis centers, is expected to contribute further. DaVita is a leading provider of dialysis services in the United States to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services, primarily in dialysis centers and contracted hospitals across the country. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. Image Source: Zac
Show less
Read more
Impact Snapshot
Event Time:
DVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVA alerts
High impacting DaVita Inc. news events
Weekly update
A roundup of the hottest topics
DVA
News
- DaVita's "Move It With Purpose" Sets Record Participation in Support of Global HealthPR Newswire
- DaVita Inc. to Participate in UBS Global Healthcare Conference 2024PR Newswire
- DaVita Inc. (NYSE: DVA) had its price target raised by analysts at Barclays PLC from $150.00 to $164.00. They now have an "equal weight" rating on the stock.MarketBeat
- DaVita Inc. 3rd Quarter 2024 ResultsPR Newswire
- DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS ProgramPR Newswire
DVA
Earnings
- 10/29/24 - Miss
DVA
Sec Filings
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- DVA's page on the SEC website